Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

2020 ◽  
Author(s):  
Keyword(s):  
Randomized Study ◽  
Circulating Dna ◽  
Oncology Patient ◽  
Improve Outcome

Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens.

1998 ◽  
Vol 16 (5) ◽  
pp. 1849-1851 ◽  
Author(s):  
M Markman ◽  
P G Rose ◽  
E Jones ◽  
I R Horowitz ◽  
A Kennedy ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Cancer Patients ◽  
Treatment Strategy ◽  
Randomized Study ◽  
Advanced Ovarian Cancer ◽  
Primary Carcinoma ◽  
Primary Therapy ◽  
Prolonged Infusion ◽  
Fallopian Tube Cancer ◽  
Improve Outcome

PURPOSE To test the hypothesis that prolonged infusion of paclitaxel (96 hours) might overcome resistance to shorter infusion schedules (3 or 24 hours) in ovarian cancer. PATIENTS AND METHODS A total of 30 patients with advanced ovarian cancer (24 patients), primary carcinoma of the peritoneum (four patients), or fallopian tube cancer (two patients) who previously had received paclitaxel administered on either a 3-hour or 24-hour schedule were treated with the agent delivered as a 96-hour infusion (30 to 35 mg/m2/d x 4 days) on an every 3-week program. RESULTS Although the regimen generally was well tolerated, no objective responses were observed. CONCLUSION In patients with ovarian cancer who have shown resistance to shorter paclitaxel infusion schedules, ninety-six hour infusional paclitaxel is an inactive treatment strategy. This makes it less likely that protracted infusion of paclitaxel will improve outcome when used as part of primary therapy of ovarian cancer. An ongoing randomized study will answer that question.

1374: A Two Years Follow-Up, Prospective Randomized Study on Cystocele Repair with or without Pelvicol Implant

2007 ◽  
Vol 177 (4S) ◽  
pp. 453-453 ◽  
Author(s):  
Ervin Kocjancic ◽  
Simone Crivellaro ◽  
Fabio Bernasconi ◽  
Fabio Magatti ◽  
Bruno Frea ◽  
...  
Keyword(s):  
Randomized Study ◽  
Prospective Randomized Study

1949: Six Month Randomized Study Comparing Cyclosporine Microemulsion with C2 Monitoring and Tacrolimus in De Novo Kidney Transplantation

2004 ◽  
Vol 171 (4S) ◽  
pp. 515-515
Author(s):  
Felipe G. Balbontin ◽  
Bryce Kiberd ◽  
Philip Belitsky ◽  
Dharm Singh ◽  
Albert Fraser ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
De Novo ◽  
Randomized Study ◽  
C2 Monitoring ◽  
Cyclosporine Microemulsion

532: Intravesical Resiniferatoxin Versus Botulinum-A Toxin Injections in Patients with Neurogenic Detrusor Overactivity: A Prospective Randomized Study

2004 ◽  
Vol 171 (4S) ◽  
pp. 142-142 ◽  
Author(s):  
Antonella Giannantoni ◽  
Savino M. Di Stasi ◽  
Robert L. Stephen ◽  
Gerardo Pizzirusso ◽  
Ettore Mearini ◽  
...  
Keyword(s):  
Detrusor Overactivity ◽  
Randomized Study ◽  
Prospective Randomized Study ◽  
Neurogenic Detrusor Overactivity ◽  
Botulinum A Toxin

Nutritional Support of the Surgical Oncology Patient

1991 ◽  
Vol 5 (1) ◽  
pp. 125-145 ◽  
Author(s):  
Mike K. Chen ◽  
Wiley W. Souba ◽  
Edward M. Copeland
Keyword(s):  
Nutritional Support ◽  
Surgical Oncology ◽  
Oncology Patient
Sign in / Sign up

Export Citation Format

Share Document